CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-09 | Nazzi Gianfranco EVP, International Markets | Sale | −17,480 | $12.72 | $222K | 60,410.36 |
| 2021-02-09 | Nazzi Gianfranco EVP, International Markets | Option exercise · Restricted Share Units | −11,941 | 11,941 | ||
| 2021-02-09 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise | +16,120 | 61,680.51 | ||
| 2021-02-09 | Fridriksdottir Hafrun Executive VP, Global R&D | Grant or award | +67,852 | 129,532.51 | ||
| 2021-02-09 | Fridriksdottir Hafrun Executive VP, Global R&D | Sale | −5,857 | $12.69 | $74K | 123,675.51 |
| 2021-02-09 | Fridriksdottir Hafrun Executive VP, Global R&D | Sale | −23,639 | $12.69 | $300K | 100,036.51 |
| 2021-02-09 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −16,120 | 16,121 | ||
| 2021-02-09 | Fridriksdottir Hafrun Executive VP, Global R&D | Grant or award · Restricted Share Units | +37,884 | 37,884 | ||
| 2021-02-09 | Drape Eric Executive VP Global Operations | Option exercise | +6,567 | 28,061 | ||
| 2021-02-09 | Drape Eric Executive VP Global Operations | Grant or award | +27,643 | 55,704 | ||
| 2021-02-09 | Drape Eric Executive VP Global Operations | Sale | −3,452 | $12.72 | $44K | 52,252 |
| 2021-02-09 | Drape Eric Executive VP Global Operations | Sale | −14,527 | $12.72 | $185K | 37,725 |
| 2021-02-09 | Drape Eric Executive VP Global Operations | Option exercise · Restricted Share Units | −6,567 | 6,568 | ||
| 2021-02-09 | Drape Eric Executive VP Global Operations | Grant or award · Restricted Share Units | +37,884 | 37,884 | ||
| 2021-02-09 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise | +13,135 | 33,773.7 | ||
| 2021-02-09 | Dethlefs Sven EVP Global Marketing&Portfolio | Grant or award | +55,287 | 89,060.7 | ||
| 2021-02-09 | Dethlefs Sven EVP Global Marketing&Portfolio | Sale | −5,695 | $12.69 | $72K | 83,365.7 |
| 2021-02-09 | Dethlefs Sven EVP Global Marketing&Portfolio | Sale | −23,962 | $12.69 | $304K | 59,403.7 |
| 2021-02-09 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise · Restricted Share Units | −13,135 | 13,135 | ||
| 2021-02-09 | Daniell Richard Exec. VP, European Commercial | Option exercise | +13,135 | 23,900 |
Page 52 of 76 · 1,517 trades